... palliation, 35 to reduce symp-toms, and 14 as adjuvant therapy. The chemotherapy con-sisted of mitomycin C with or without gemcitabine, and embolization was performed with lipiodol and starchmicrospheres ... com-pleted planned therapy, the extent of hepatic and systemictoxicity, and, if the data allowed, the response to therapy.All subjects have been evaluated for safety. Exposure to the study drug is summarized ... site. Acentral assessment of tumor response was performed for all patients by the Principal Investigator at University of Louisville. When there was a discrepancy, the Registry PI and the site PI...